Evidence map›Paper›PMID 33918663›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma Cells.

Clarisse Brossard, Manuel Vlach, Elise Vène, Catherine Ribault, Vincent Dorcet, Nicolas Noiret, Pascal Loyer, Nicolas Lepareur, Sandrine Cammas-Marion

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Polymalic acid for translational nanomedicine.Journal of nanobiotechnology · 2022
    Review
  5. Article
  6. Article
  7. Circumsporozoite Protein ofPharmaceutics · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Clarisse BrossardUniversity Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR, UMR 6226, ScanMAT, UMS2001, F-35000 Rennes, France.
Manuel VlachINSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, University Rennes, F-35000 Rennes, France.
Elise VèneINSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, University Rennes, F-35000 Rennes, France.
Catherine RibaultINSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, University Rennes, F-35000 Rennes, France.
Vincent DorcetUniversity Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR, UMR 6226, ScanMAT, UMS2001, F-35000 Rennes, France.
Nicolas NoiretUniversity Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR, UMR 6226, ScanMAT, UMS2001, F-35000 Rennes, France.
Pascal LoyerINSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, University Rennes, F-35000 Rennes, France.ORCID 0000-0002-5656-2673
Nicolas LepareurINSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, University Rennes, F-35000 Rennes, France.ORCID 0000-0001-9860-5451
Sandrine Cammas-MarionUniversity Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR, UMR 6226, ScanMAT, UMS2001, F-35000 Rennes, France.ORCID 0000-0001-6552-8082
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

Fondation pour la Recherche Médicale DCM20181039540
6 · The paper itself

Abstract

Recently, short synthetic peptides have gained interest as targeting agents in the design of site-specific nanomedicines. In this context, our work aimed at developing new tools for the diagnosis and/or therapy of hepatocellular carcinoma (HCC) by grafting the hepatotropic George Baker (GB) virus A (GBVA10-9) and

Indexed as

circumsporozoite protein of Plasmodium berghei(Co)polymers end-functionalized with peptideGB virus Ahuman hepatoma cellsmultifunctional nanoparticlespoly(malic acid) derivatives

Identifiers

PMID33918663
PMCPMC8070460
OpenAlexW3154438628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.